Replies to post #688003 on NorthWest Biotherapeutics Inc (NWBO)

[JFR161162]

Company will be sold 2-4 months after approval in the UK.

[manibiotech]

Agree

[scotty3371]

Actually, it will sell itself very easily.

Most neurosurgeons that deal with glioblastoma are following this trial carefully.

There are only about 50k brain surgeons on our planet.

[Doc logic]

dennisdave,

I guess you missed the part about Walgreens preparing for DCVax-L distribution and point of sale instructions. I am pretty sure a franchise model based on Advent and perhaps CRL being training centers as well as manufacturing partners might be more than adequate to train big pharma franchisees. Linda also has other connections to get the help needed from and every trial site is trained in the basics of artisan administration and followup. A little training on how digitization works and good to go because these centers will be serving as the sales team as initial points of contact while eventual SOC designation will take care of much of the rest. By the way, this new language is in the risk section because of the likelihood of approval in the first place. Wrap your head around that; ). Best wishes.

[HappyLibrarian]

In that case, what do you think the buyout price would be?

[Investor082]

I agree with you 100%. They need a dedicated team in the UK for not only sales and marketing but also finance, support, operations, etc. They ought to have hired these people and put the processes in place couple of months ago. Look at what Advent has been doing on the hiring side in terms of setting up manufacturing. Although Advent needed to be very aggressive on the hiring side given the nature of the product. NWBO should have still hired close to a dozen folks to support commercialization effort in the UK.

All indications point to a big pharma partnership where they take on UK sales. In return, NWBO receives a large upfront payment and some percentage of sales revenue on an ongoing basis. Anything other than this or a buyout (which is highly unlikely at this time given our share price) will be another let down from this management. They have had several years to plan for this.